XPH SPDR S&P Pharmaceuticals ETF
*Unless otherwise stated, data provided by FactSet.
What is XPH?
XPH tracks an equal-weighted index of US pharmaceutical companies.
XPH Factset Analytics Insight
XPH offers equal-weighted exposure to a narrow selection of US pharmaceutical companies, stretching across all market caps. XPH's weighting scheme causes it to be far less concentrated than the industry, which is dominated by a handful of mega-cap names like J&J, Pfizer and Merck. The fund also introduces a heavy tilt to mid- and small-caps, which makes for a rather volatile fund relative to the industry. Overall, XPH is a solid way to capture a less concentrated version of the pharma market. The index is rebalanced quarterly.
PERFORMANCE [as of 03/20/23]
1 MONTH
3 MONTHS
YTD
1 YEAR
3 YEARS
5 YEARS
10 YEARS
XPH
-5.18%
0.85%
0.31%
-8.44%
9.82%
0.29%
4.79%
XPH (NAV)
-5.12%
0.93%
0.31%
-8.31%
9.88%
0.31%
4.80%
MSCI USA IMI / Pharmaceuticals -IND
--
--
--
--
--
--
--
All returns over 1 year are annualized. All returns are total returns unless otherwise stated.
XPH Summary Data
06/19/06
Open-Ended Fund
0.35%
$193.08M
$2.12M
0.11%
XPH Portfolio Data
$62.03B
1,966.00
3.14
1.48%
N/A
42
XPH Index Data
S&P Pharmaceuticals Select Industry
Equal
Market Cap
MSCI USA IMI / Pharmaceuticals -IND
XPH Portfolio Management
0.35%
0.31%
0.57%
-0.03%
XPH Tax Exposures
20.00% / 39.60%
--
Qualified dividends
No
XPH Fund Structure
Open-Ended Fund
No
Yes
-- / --
N/A
N/A
Low
Daily
XPH Factset Analytics Block Liquidity
As of 03/21/23
5
4
3
2
1
This measurement shows how easy it is to trade a $1 million USD block of XPH. XPH is rated a 5 out of 5.
XPH Tradability
50,269
$2.12M
24,843
$1.05M
0.11%
$0.05
-0.01%
0.16% / -0.16%
None
100.00%
50,000
0.50
0.01%
0.14%
321
$40.99
5
XPH Sector/Industry Breakdown
XPH
Segment Benchmark
99.60%
--
0.40%
--
XPH Top 10 Holdings[View All]
Eli Lilly and Company
4.36%
Pfizer Inc.
4.27%
Zoetis, Inc. Class A
4.23%
Johnson & Johnson
4.18%
Organon & Co.
4.07%
Catalent Inc
4.06%
42.48%
XPH Countries
XPH
Segment Benchmark
99.84%
--
XPH Regions
XPH
Segment Benchmark
99.84%
--
XPH Economic Development
XPH
Segment Benchmark
99.84%
--
0.00%
--
XPH Performance Statistics
--
--
--
--
--
MSCI USA IMI / Pharmaceuticals -IND
XPH Benchmark Comparison Summary
XPH
Segment Benchmark
42
--
$62.03B
--
1,966.00
--
3.14
--
1.06%
--
Medium
--
XPH Benchmark Comparison Market Cap Size
XPH
Segment Benchmark
31.76%
--
38.99%
--
26.00%
--
3.09%
--